330 related articles for article (PubMed ID: 37097160)
21. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
22. Expanding the scope of CRISPR/Cas9-mediated genome editing in plants using an xCas9 and Cas9-NG hybrid.
Niu Q; Wu S; Li Y; Yang X; Liu P; Xu Y; Lang Z
J Integr Plant Biol; 2020 Apr; 62(4):398-402. PubMed ID: 31702097
[TBL] [Abstract][Full Text] [Related]
23. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
Hu X; Meng X; Liu Q; Li J; Wang K
Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
[TBL] [Abstract][Full Text] [Related]
24. Genome editing in plants by engineered CRISPR-Cas9 recognizing NG PAM.
Endo M; Mikami M; Endo A; Kaya H; Itoh T; Nishimasu H; Nureki O; Toki S
Nat Plants; 2019 Jan; 5(1):14-17. PubMed ID: 30531939
[TBL] [Abstract][Full Text] [Related]
25. SpCas9- and LbCas12a-Mediated DNA Editing Produce Different Gene Knockout Outcomes in Zebrafish Embryos.
Meshalkina DA; Glushchenko AS; Kysil EV; Mizgirev IV; Frolov A
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32635161
[TBL] [Abstract][Full Text] [Related]
26. Cas9-NG Greatly Expands the Targeting Scope of the Genome-Editing Toolkit by Recognizing NG and Other Atypical PAMs in Rice.
Ren B; Liu L; Li S; Kuang Y; Wang J; Zhang D; Zhou X; Lin H; Zhou H
Mol Plant; 2019 Jul; 12(7):1015-1026. PubMed ID: 30928635
[TBL] [Abstract][Full Text] [Related]
27. The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells.
Lee CM; Cradick TJ; Bao G
Mol Ther; 2016 Mar; 24(3):645-54. PubMed ID: 26782639
[TBL] [Abstract][Full Text] [Related]
28. DNA targeting by Clostridium cellulolyticum CRISPR-Cas9 Type II-C system.
Fedorova I; Arseniev A; Selkova P; Pobegalov G; Goryanin I; Vasileva A; Musharova O; Abramova M; Kazalov M; Zyubko T; Artamonova T; Artamonova D; Shmakov S; Khodorkovskii M; Severinov K
Nucleic Acids Res; 2020 Feb; 48(4):2026-2034. PubMed ID: 31943070
[TBL] [Abstract][Full Text] [Related]
29. SpRY Cas9 Can Utilize a Variety of Protospacer Adjacent Motif Site Sequences To Edit the Candida albicans Genome.
Evans BA; Bernstein DA
mSphere; 2021 May; 6(3):. PubMed ID: 34011687
[No Abstract] [Full Text] [Related]
30. Engineered CRISPR-Cas9 nuclease with expanded targeting space.
Nishimasu H; Shi X; Ishiguro S; Gao L; Hirano S; Okazaki S; Noda T; Abudayyeh OO; Gootenberg JS; Mori H; Oura S; Holmes B; Tanaka M; Seki M; Hirano H; Aburatani H; Ishitani R; Ikawa M; Yachie N; Zhang F; Nureki O
Science; 2018 Sep; 361(6408):1259-1262. PubMed ID: 30166441
[TBL] [Abstract][Full Text] [Related]
31. [Cas9 protein variant VQR recognizes NGAC protospacer adjacent motif in rice].
Xin GW; Hu XX; Wang KJ; Wang XC
Yi Chuan; 2018 Dec; 40(12):1112-1119. PubMed ID: 30559100
[TBL] [Abstract][Full Text] [Related]
32. Portable CRISPR-Cas9
Goh YJ; Barrangou R
Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33397707
[TBL] [Abstract][Full Text] [Related]
33. Using
Zhang Y; Cai Y; Sun S; Han T; Chen L; Hou W
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361580
[TBL] [Abstract][Full Text] [Related]
34. Structural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9.
Anders C; Bargsten K; Jinek M
Mol Cell; 2016 Mar; 61(6):895-902. PubMed ID: 26990992
[TBL] [Abstract][Full Text] [Related]
35. High-throughput analysis of the activities of xCas9, SpCas9-NG and SpCas9 at matched and mismatched target sequences in human cells.
Kim HK; Lee S; Kim Y; Park J; Min S; Choi JW; Huang TP; Yoon S; Liu DR; Kim HH
Nat Biomed Eng; 2020 Jan; 4(1):111-124. PubMed ID: 31937939
[TBL] [Abstract][Full Text] [Related]
36. Rational Selection of CRISPR-Cas Triggering Homology-Directed Repair in Human Cells.
Li F; Zhou C; Tu T; Liu Y; Lv X; Wang B; Song Z; Zhao Q; Liu C; Gu F; Zhao J
Hum Gene Ther; 2021 Mar; 32(5-6):302-309. PubMed ID: 33323021
[TBL] [Abstract][Full Text] [Related]
37. Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies.
Allemailem KS; Almatroudi A; Rahmani AH; Alrumaihi F; Alradhi AE; Alsubaiyel AM; Algahtani M; Almousa RM; Mahzari A; Sindi AAA; Dobie G; Khan AA
Int J Nanomedicine; 2024; 19():5335-5363. PubMed ID: 38859956
[TBL] [Abstract][Full Text] [Related]
38. The CRISPR-Cas system - from bacterial immunity to genome engineering.
Czarnek M; Bereta J
Postepy Hig Med Dosw (Online); 2016 Sep; 70(0):901-16. PubMed ID: 27594566
[TBL] [Abstract][Full Text] [Related]
39. Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
Heler R; Samai P; Modell JW; Weiner C; Goldberg GW; Bikard D; Marraffini LA
Nature; 2015 Mar; 519(7542):199-202. PubMed ID: 25707807
[TBL] [Abstract][Full Text] [Related]
40. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.
Walton RT; Christie KA; Whittaker MN; Kleinstiver BP
Science; 2020 Apr; 368(6488):290-296. PubMed ID: 32217751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]